U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Lung neuroendocrine neoplasm

MedGen UID:
277303
•Concept ID:
C1334452
•
Neoplastic Process
Synonyms: Bronchial neuroendocrine tumor; lung NET; Lung Neuroendocrine Neoplasm; lung neuroendocrine neoplasm; lung neuroendocrine tumor; lung neuroendocrine tumor, well differentiated, low or intermediate grade; lung neuroendocrine tumour; Neuroendocrine neoplasm of lung; Neuroendocrine Neoplasm of Lung; neuroendocrine neoplasm of lung; Neuroendocrine Neoplasm of the Lung; neuroendocrine neoplasm of the lung; Pulmonary Neuroendocrine Neoplasm; pulmonary neuroendocrine neoplasm; pulmonary neuroendocrine tumor; pulmonary neuroendocrine tumour
SNOMED CT: Neuroendocrine neoplasm of lung (707594002); Bronchial neuroendocrine tumor (707594002)
 
Monarch Initiative: MONDO:0005454

Definition

A neoplasm with neuroendocrine differentiation that arises from the lung. This category includes typical carcinoid tumor, atypical carcinoid tumor, small cell carcinoma, large cell neuroendocrine carcinoma, and combined carcinoma. [from NCI]

Professional guidelines

PubMed

Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline - Update 2022.
Gauci ML, Aristei C, Becker JC, Blom A, Bataille V, Dreno B, Del Marmol V, Forsea AM, Fargnoli MC, Grob JJ, Gomes F, Hauschild A, Hoeller C, Harwood C, Kelleners-Smeets N, Kaufmann R, Lallas A, Malvehy J, Moreno-Ramirez D, Peris K, Pellacani G, Saiag P, Stratigos AJ, Vieira R, Zalaudek I, van Akkooi ACJ, Lorigan P, Garbe C, Lebbé C; European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organization for Research and Treatment of Cancer (EORTC)
Eur J Cancer 2022 Aug;171:203-231. Epub 2022 Jun 19 doi: 10.1016/j.ejca.2022.03.043. PMID: 35732101
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Ganti AKP, Loo BW, Bassetti M, Blakely C, Chiang A, D'Amico TA, D'Avella C, Dowlati A, Downey RJ, Edelman M, Florsheim C, Gold KA, Goldman JW, Grecula JC, Hann C, Iams W, Iyengar P, Kelly K, Khalil M, Koczywas M, Merritt RE, Mohindra N, Molina J, Moran C, Pokharel S, Puri S, Qin A, Rusthoven C, Sands J, Santana-Davila R, Shafique M, Waqar SN, Gregory KM, Hughes M
J Natl Compr Canc Netw 2021 Dec;19(12):1441-1464. doi: 10.6004/jnccn.2021.0058. PMID: 34902832Free PMC Article
Management of toxicities of immune checkpoint inhibitors.
Spain L, Diem S, Larkin J
Cancer Treat Rev 2016 Mar;44:51-60. Epub 2016 Feb 6 doi: 10.1016/j.ctrv.2016.02.001. PMID: 26874776

Recent clinical studies

Etiology

Updates on lung neuroendocrine neoplasm classification.
Vocino Trucco G, Righi L, Volante M, Papotti M
Histopathology 2024 Jan;84(1):67-85. Epub 2023 Oct 4 doi: 10.1111/his.15058. PMID: 37794655
Serum tumor markers for detection of bone metastases in patients with lung neuroendocrine neoplasms".
Rosiek V, Wójcik-Giertuga M, Kos-Kudła B
Cancer Treat Res Commun 2022;31:100533. Epub 2022 Feb 15 doi: 10.1016/j.ctarc.2022.100533. PMID: 35202905
Clinical implications of lung neuroendocrine neoplasm classification.
Metovic J, Barella M, Harari S, Pattini L, Albini A, Sonzogni A, Veronesi G, Papotti M, Pelosi G
Expert Rev Anticancer Ther 2021 Apr;21(4):377-387. Epub 2020 Dec 24 doi: 10.1080/14737140.2021.1862654. PMID: 33306420

Diagnosis

Updates on lung neuroendocrine neoplasm classification.
Vocino Trucco G, Righi L, Volante M, Papotti M
Histopathology 2024 Jan;84(1):67-85. Epub 2023 Oct 4 doi: 10.1111/his.15058. PMID: 37794655
The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015.
Nicholson AG, Tsao MS, Beasley MB, Borczuk AC, Brambilla E, Cooper WA, Dacic S, Jain D, Kerr KM, Lantuejoul S, Noguchi M, Papotti M, Rekhtman N, Scagliotti G, van Schil P, Sholl L, Yatabe Y, Yoshida A, Travis WD
J Thorac Oncol 2022 Mar;17(3):362-387. Epub 2021 Nov 20 doi: 10.1016/j.jtho.2021.11.003. PMID: 34808341
Lung neuroendocrine neoplasms: recent progress and persistent challenges.
Rekhtman N
Mod Pathol 2022 Jan;35(Suppl 1):36-50. Epub 2021 Oct 18 doi: 10.1038/s41379-021-00943-2. PMID: 34663914Free PMC Article
The Ki-67 antigen in the new 2021 World Health Organization classification of lung neuroendocrine neoplasms.
Pelosi G, Travis WD
Pathologica 2021 Oct;113(5):377-387. doi: 10.32074/1591-951X-542. PMID: 34837096Free PMC Article
Clinical implications of lung neuroendocrine neoplasm classification.
Metovic J, Barella M, Harari S, Pattini L, Albini A, Sonzogni A, Veronesi G, Papotti M, Pelosi G
Expert Rev Anticancer Ther 2021 Apr;21(4):377-387. Epub 2020 Dec 24 doi: 10.1080/14737140.2021.1862654. PMID: 33306420

Therapy

Treatment of atypical pulmonary carcinoid with combination ipilimumab and nivolumab.
Nestor J, Barnaby K, Esposito M, Seetharamu N
BMJ Case Rep 2019 Nov 28;12(11) doi: 10.1136/bcr-2019-231029. PMID: 31780616Free PMC Article

Prognosis

Updates on lung neuroendocrine neoplasm classification.
Vocino Trucco G, Righi L, Volante M, Papotti M
Histopathology 2024 Jan;84(1):67-85. Epub 2023 Oct 4 doi: 10.1111/his.15058. PMID: 37794655
The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015.
Nicholson AG, Tsao MS, Beasley MB, Borczuk AC, Brambilla E, Cooper WA, Dacic S, Jain D, Kerr KM, Lantuejoul S, Noguchi M, Papotti M, Rekhtman N, Scagliotti G, van Schil P, Sholl L, Yatabe Y, Yoshida A, Travis WD
J Thorac Oncol 2022 Mar;17(3):362-387. Epub 2021 Nov 20 doi: 10.1016/j.jtho.2021.11.003. PMID: 34808341
Lung neuroendocrine neoplasms: recent progress and persistent challenges.
Rekhtman N
Mod Pathol 2022 Jan;35(Suppl 1):36-50. Epub 2021 Oct 18 doi: 10.1038/s41379-021-00943-2. PMID: 34663914Free PMC Article
Clinical implications of lung neuroendocrine neoplasm classification.
Metovic J, Barella M, Harari S, Pattini L, Albini A, Sonzogni A, Veronesi G, Papotti M, Pelosi G
Expert Rev Anticancer Ther 2021 Apr;21(4):377-387. Epub 2020 Dec 24 doi: 10.1080/14737140.2021.1862654. PMID: 33306420

Clinical prediction guides

[(68)Ga]Ga-Pentixafor PET/CT imaging for in vivo CXCR4 receptor mapping in different lung cancer histologic sub-types: correlation with quantitative receptors' density by immunochemistry techniques.
Watts A, Singh B, Singh H, Bal A, Kaur H, Dhanota N, Arora SK, Mittal BR, Behera D
Eur J Nucl Med Mol Imaging 2023 Mar;50(4):1216-1227. Epub 2022 Dec 9 doi: 10.1007/s00259-022-06059-2. PMID: 36482077
Lung neuroendocrine neoplasms: recent progress and persistent challenges.
Rekhtman N
Mod Pathol 2022 Jan;35(Suppl 1):36-50. Epub 2021 Oct 18 doi: 10.1038/s41379-021-00943-2. PMID: 34663914Free PMC Article
Clinical implications of lung neuroendocrine neoplasm classification.
Metovic J, Barella M, Harari S, Pattini L, Albini A, Sonzogni A, Veronesi G, Papotti M, Pelosi G
Expert Rev Anticancer Ther 2021 Apr;21(4):377-387. Epub 2020 Dec 24 doi: 10.1080/14737140.2021.1862654. PMID: 33306420

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Reviews

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...